Radiopharm Theranostics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 25, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	51	17	36	38	-
Market Cap Growth	91.43%	-50.90%	-7.01%	-	-
Enterprise Value	14	16	13	6	-
Last Close Price	0.02	0.04	0.10	0.14	-
PS Ratio	155.30	8.93	5.74	-	-
PB Ratio	0.99	0.64	0.78	0.61	-
P/TBV Ratio	9.87	-	-	5.56	-
EV/Sales Ratio	41.47	8.02	2.04	-	-
Debt / Equity Ratio	-	-	-	-	-0.47
Asset Turnover	0.00	0.03	0.08	-	-
Quick Ratio	3.25	1.11	1.22	3.43	0.21
Current Ratio	3.37	1.30	1.23	3.46	0.21
Return on Equity (ROE)	-112.21%	-131.49%	-63.78%	-96.82%	-
Return on Assets (ROA)	-28.95%	-30.04%	-22.57%	-29.86%	-
Return on Capital (ROIC)	-59.05%	-60.55%	-32.93%	-39.60%	-
Earnings Yield	-83.75%	-274.09%	-97.15%	-79.40%	-
FCF Yield	-	-131.34%	-65.25%	-25.86%	-
Buyback Yield / Dilution	-243.78%	-26.36%	-68.74%	-	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.